Tumor Markers, Biological

Publication Title: 
Annals of Medicine

The biology of telomeres and telomerase has been the subject of intensive investigative effort since it became evident that they play a significant role in two important biological processes, the loss of cellular replicative capacity inherent to organismal ageing and the unrestricted cell proliferation characteristic of carcinogenesis. Telomere shortening in normal cells is a result of DNA replication events, and reduction beyond a critical length is a signal for cellular senescence.

Author(s): 
Urquidi, V.
Tarin, D.
Goodison, S.
Publication Title: 
Medical Oncology (Northwood, London, England)

The forkhead box proteins (FOXO proteins) comprise a large family of functionally diverse transcription factors involved in cellular proliferation, transformation, differentiation and longevity. Recently, ubiquitination and proteasome degradation of FOXO3a have been reported. In this study, we investigated the role of FOXO3a and Skp2 in human ovarian cancer. We detected the expression of FOXO3a and Skp2 in ovarian cancer by immunohistochemistry (IHC) and analyzed the relationship of FOXO3a and Skp2 with clinicopathological parameters, including prognosis.

Author(s): 
Lu, Mudan
Zhao, Yueming
Xu, Fei
Wang, Yong
Xiang, Jingying
Chen, Daozhen
Publication Title: 
Toxins

Tumor endothelium marker-8 (TEM8) and capillary morphogenesis protein-2 (CMG2) are the two well-characterized anthrax toxin receptors, each containing a von Willebrand factor A (vWA) domain responsible for anthrax protective antigen (PA) binding. Recently, a cell-based analysis was used to implicate another vWA domain-containing protein, integrin ?1 as a third anthrax toxin receptor. To explore whether proteins other than TEM8 and CMG2 function as anthrax toxin receptors in vivo, we challenged mice lacking TEM8 and/or CMG2.

Author(s): 
Liu, Shihui
Zhang, Yi
Hoover, Benjamin
Leppla, Stephen H.
Publication Title: 
The Journal of Biological Chemistry

Artemisinin and its derivatives are important new antimalarial drugs. When Plasmodium falciparum-infected erythrocytes are incubated with [10-3H]dihydroartemisinin, several malaria-specific proteins become labeled. One of these proteins is the P. falciparum translationally controlled tumor protein (TCTP) homolog. In vitro, dihydroartemisinin reacts covalently with recombinant TCTP in the presence of hemin. The association between drug and protein increases with increasing drug concentration, plateauing at approximately 1 drug/TCTP molecule.

Author(s): 
Bhisutthibhan, J.
Pan, X. Q.
Hossler, P. A.
Walker, D. J.
Yowell, C. A.
Carlton, J.
Dame, J. B.
Meshnick, S. R.
Publication Title: 
Antimicrobial Agents and Chemotherapy

Artemisinin and its derivatives are important new antimalarials which are now used widely in Southeast Asia. Clinically relevant artemisinin resistance has not yet been reported but is likely to occur. In order to understand how the malaria parasite might become resistant to this drug, we studied artemisinin resistance in the murine malaria parasite Plasmodium yoelii. The artemisinin-resistant strain (ART), which is approximately fourfold less sensitive to artemisinin than the sensitive NS strain, accumulated 43% less radiolabeled drug in vitro (P < 0.01).

Author(s): 
Walker, D. J.
Pitsch, J. L.
Peng, M. M.
Robinson, B. L.
Peters, W.
Bhisutthibhan, J.
Meshnick, S. R.
Publication Title: 
Antimicrobial Agents and Chemotherapy

Artemisinin and its derivatives are endoperoxide-containing antimalarial drugs that appear to form adducts in situ with the Plasmodium falciparum translationally controlled tumor protein (TCTP) homolog. Immunoprecipitation with antibody to recombinant TCTP suggests that adducts may form with both monomeric and dimeric TCTP.

Author(s): 
Bhisutthibhan, J.
Meshnick, S. R.
Publication Title: 
Malaria Journal

BACKGROUND: Evaluating copy numbers of given genes in Plasmodium falciparum parasites is of major importance for laboratory-based studies or epidemiological surveys. For instance, pfmdr1 gene amplification has been associated with resistance to quinine derivatives and several genes involved in anti-oxidant defence may play an important role in resistance to antimalarial drugs, although their potential involvement has been overlooked.

Author(s): 
Ferreira, Isabel D.
Rosário, Virgílio E. do
Cravo, Pedro V. L.
Publication Title: 
Antimicrobial Agents and Chemotherapy

Resistance of Plasmodium falciparum to drugs such as chloroquine and sulfadoxine-pyrimethamine is a major problem in malaria control. Artemisinin (ART) derivatives, particularly in combination with other drugs, are thus increasingly used to treat malaria, reducing the probability that parasites resistant to the components will emerge. Although stable resistance to artemisinin has yet to be reported from laboratory or field studies, its emergence would be disastrous because of the lack of alternative treatments.

Author(s): 
Afonso, A.
Hunt, P.
Cheesman, S.
Alves, A. C.
Cunha, C. V.
do Rosário, V.
Cravo, P.
Publication Title: 
FEBS letters

Dehydroartemisinin (DHA) is an effective anti-malaria agent. Fortilin is an anti-apoptotic molecule overexpressed in many human cancers. Here, we show that DHA binds human fortilin, increases the ubiquitination of fortilin, shortens fortilin's half-life in a proteasome-dependent fashion, and reduces cellular levels of fortilin in varieties of cells. DHA induced DNA fragmentation in U2OS cells in a fortilin-dependent manner.

Author(s): 
Fujita, Takayuki
Felix, Kumar
Pinkaew, Decha
Hutadilok-Towatana, Nongporn
Liu, Zhihe
Fujise, Ken
Publication Title: 
Asian Pacific journal of cancer prevention: APJCP

OBJECTIVE: Lung cancer is one of the malignant tumors with greatest morbidity and mortality around the world. The keys to targeted therapy are discovery of lung cancer biomarkers to facilitate improvement of survival and quality of life for the patients with lung cancer. Translationally controlled tumor protein (TCTP) is one of the most overexpressed proteins in human lung cancer cells by comparison to the normal cells, suggesting that it might be a good biomarker for lung cancer.

Author(s): 
Liu, Lian-Ke
Wu, Heng-Fang
Guo, Zhi-Rui
Chen, Xiang-Jian
Yang, Di
Shu, Yong-Qian
Zhang, Ji-Nan

Pages

Subscribe to RSS - Tumor Markers, Biological